Rémy Duléry

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (22)

Collaborators (10)

Mohamad Mohty

Sara Villar

Clinica Universidad de Navarra

Christian Chabannon

Professor in Cell Biology

Aix-Marseille Université Faculté de Medecine

Barbora Weinbergerova

Masaryk University

CZECH REPUBLIC

Eve TODESCO

Sorbonne Université

Rizwan Romee

Associate Professor

Dana-Farber Cancer Institute

UNITED STATES

Roman Shapiro

Assistant Professor

Harvard University

UNITED STATES

Caroline Besson

Martin Kolditz

University Hospital Carl Gustav Carus

Andreas Glenthøj

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rémy Duléry

Research Interests

Explore related searches

Contact this professor

Articles (22)

Collaborators (10)

Mohamad Mohty

Sara Villar

Christian Chabannon

Barbora Weinbergerova

Eve TODESCO

Rizwan Romee

Roman Shapiro

Caroline Besson

Martin Kolditz

Andreas Glenthøj

Make your next move.

Rémy Duléry

Research Interests

Explore related searches

Contact this professor

Articles (22)

T cell malignancies after CAR T cell therapy in the DESCAR-T registry

Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registry

Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival

Haploidentical hematopoietic cell transplantation as a platform for natural killer cell immunotherapy

Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.

Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.

Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.

Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact

Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma

Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation

Autologous hematopoietic cell transplantation as a part of a sequential multi-phase therapeutic approach (R-COPADM/CYVE/ASCT) as first-line treatment of high-grade B-cell lymphoma: results of a retrospective study with long-term follow-up

Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies

Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases

Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation

On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

Low incidence of hyperacute graft‐versus‐host disease (GVHD) with effective GVHD prophylaxis based on anti‐thymocyte globulin

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP

Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Société Francophone de Greffe de Moelle et de Therapie Cellulaire

Collaborators (10)

Mohamad Mohty

Sara Villar

Christian Chabannon

Barbora Weinbergerova

Eve TODESCO

Rizwan Romee

Roman Shapiro

Caroline Besson

Martin Kolditz

Andreas Glenthøj

Make your next move.